Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Statins and cancer risk
Your Article Summary
Second-Line Rescue Therapy With Levofloxacin After H. pylori Treatment Failure: A Spanish Multicenter Study of 300 Patients
The American Journal of Gastroenterology, 01/22/08
Gisbert JP et al. - Quadruple therapy is generally recommended as second-line therapy after Helicobacter pylori (H. pylori) eradication failure...Ten-day levofloxacin-based rescue therapy constitutes an encouraging second-line strategy, representing an alternative to quadruple therapy in patients with previous proton pump inhibitor-clarithromycin-amoxicillin failure, being simple and safe
| Previous Article | Next Article |
Today in Antimicrobials...keeping you current
Receive free subspecialty "5-minute updates" via email
Empiric Antimicrobial Therapy for Pediatric Skin and Soft-Tissue Infections in the Era of Methicillin-Resistant Staphylococcus aureus
Pediatrics, 05/27/09
Caspofungin for the treatment of candidaemia in patients with haematological malignancies
Clinical Microbiology and Infection, 06/29/09
Trends in broad-spectrum antibiotic prescribing for children with acute otitis media in the United States, 1998-2004
BMC Pediatrics, 06/25/09
Today in Stomach/GI...keeping you current
Receive free subspecialty "5-minute updates" via email
Use of Racecadotril as Outpatient Treatment for Acute Gastroenteritis: A Prospective, Randomized, Parallel Stud
The Journal of Pediatrics, 06/30/09
Phase III noninferiority trial comparing irinotecan with oxaliplatin, fluorouracil, and leucovorin in patients with advanced colorectal carcinoma previously treated with fluorouracil: N9841
Journal of Clinical Oncology, 06/10/09
Prescribing statins to patients with nonalcoholic fatty liver disease: Real cardiovascular benefits outweigh theoretical hepatotoxic risk
Cardiovascular Drug Reviews, 06/26/09
Article Search
Sponsor


See Latest Articles


